JPMorgan lowered the firm’s price target on Demant (WILYY) to DKK 306 from DKK 319 and keeps an Overweight rating on the shares. Published first on TheFly – the ultimate source for real-time ...
Demant A/S operates as a hearing healthcare and audio technology company in Europe, North America, the Asia Pacific, Asia, and internationally. It operates through two segments: Hearing Healthcare ...
Investing.com -- Shares of Demant A/S (CSE:DEMANT) fell 5.5% as the company reported a soft revenue dynamic, despite a 4% profit beat for the fourth quarter. The Danish hearing aid manufacturer posted ...
We delivered the first integrated report with financials and sustainability. The number one purpose of Demant is to help more people hear better and part of this sustainability reporting is the ...
Demant is a world-leading hearing healthcare group that offers solutions and services to help people with hearing loss connect with the world around them. In every aspect, from hearing devices ...
Den danske høreapparatkoncern Demant kan melde om en omsætningsvækst på 4 pct. i det forgangne år. Det fremgår af et dugfrisk årsregnskab fra høreapparatsgiganten, der er blevet offentliggjort onsdag ...
Investing.com -- Shares of Demant A/S (CSE:DEMANT) fell 5.5% as the company reported a soft revenue dynamic, despite a 4% profit beat for the fourth quarter. The Danish hearing aid manufacturer ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback